Priority Research Centre for Health Behaviour, School of Medicine and Public Health, Faculty of Health, The University of Newcastle, Callaghan, New South Wales, Australia; Hunter Medical Research Institute, Newcastle, Australia.
Psychooncology. 2013 Dec;22(12):2720-8. doi: 10.1002/pon.3337. Epub 2013 Jun 26.
A patient-centred approach to discussing life expectancy with cancer patients is recommended in Western countries. However, this approach to eliciting and meeting patient preferences can be challenging for clinicians. The aims of this study were the following: (i) to examine cancer patients' preferences for life expectancy disclosure; and (ii) to explore agreement between cancer patients' preferences for, and perceived experiences of, life expectancy disclosure.
Cancer patients undergoing radiotherapy treatment in metropolitan Australia completed a cross-sectional touchscreen computer survey including optional questions about their life expectancy disclosure preferences and experiences.
Of the 208 respondents, 178 (86%) indicated that they would prefer their clinician to ask them before discussing life expectancy, and 30 (14%) indicated that they would prefer others (i.e. clinicians, family) to decide whether they were given life expectancy information. Of the 175 respondents who were classified as having a self- determined or other-determined disclosure experience, 105 (60%) reported an experience of life expectancy disclosure that was in accordance with their preferences. Cohen's κ was -0.04 (95% CI, -0.17, 0.08), indicating very poor agreement between patients' preferences for and perceived experiences of life expectancy disclosure (p = 0.74).
In light of patient-centred prognosis disclosure guidelines, our findings of a majority preference for, and experience of, a self-determined approach to life expectancy disclosure amongst radiation oncology patients are encouraging. However, poor agreement between preferences and experiences highlights that additional effort from clinicians is required in order to achieve a truly patient-centred approach to life expectancy disclosure.
在西方国家,建议采用以患者为中心的方法来讨论癌症患者的预期寿命。然而,这种引出和满足患者偏好的方法可能对临床医生具有挑战性。本研究的目的如下:(i)调查癌症患者对预期寿命披露的偏好;(ii)探讨癌症患者对预期寿命披露的偏好与其感知体验之间的一致性。
在澳大利亚大都市接受放射治疗的癌症患者完成了一项横断面触摸屏计算机调查,其中包括有关其预期寿命披露偏好和体验的可选问题。
在 208 名受访者中,178 名(86%)表示他们希望在讨论预期寿命之前,由他们的临床医生询问他们,而 30 名(14%)表示他们希望由其他人(即临床医生、家人)决定是否向他们提供预期寿命信息。在 175 名被归类为有自主或他人决定披露经历的受访者中,105 名(60%)报告说他们的预期寿命披露经历符合他们的偏好。Cohen's κ 为-0.04(95%CI,-0.17,0.08),表明患者对预期寿命披露的偏好与其感知体验之间的一致性非常差(p=0.74)。
根据以患者为中心的预后披露指南,我们的研究结果表明,大多数放射肿瘤学患者更倾向于并经历了自主决定预期寿命披露的方法,这令人鼓舞。然而,偏好和体验之间的一致性很差,这表明临床医生需要付出更多的努力,才能真正实现以患者为中心的预期寿命披露方法。